Journal
JOURNAL OF NEUROCHEMISTRY
Volume 137, Issue 2, Pages 190-199Publisher
WILEY-BLACKWELL
DOI: 10.1111/jnc.13558
Keywords
GABA; hippocampus; LTP; Parkinson's disease; Smad3; TGF-beta
Categories
Funding
- Spanish Institute of Health Carlos III [PI12/00258]
- CIBERNED [CB06/05/0033]
- European Development Regional Fund A way to achieve Europe (ERDF)
Ask authors/readers for more resources
Transforming growth factor- signaling through intracellular Smad3 has been implicated in Parkinson's disease (PD) and it fulfills an important role in the neurogenesis and synaptic plasticity that occurs in the adult dentate gyrus (DG). The long-term potentiation (LTP) induced in the DG by high-frequency stimulation of the medial perforant pathway is abolished in the DG of Smad3-deficient mice, but not in the CA1 hippocampal region. Here, we show that NMDA- and AMPA-type glutamate receptors do not participate in the inhibition of LTP associated with Smad3 deficiency. Moreover, there is no difference in the hippocampal GAD65 and GAD67 content, suggesting that GABA biosynthesis remains unaffected. Increased conductance and higher action potential firing thresholds were evident in intracellular recordings of granule cells from Smad3 deficient mice. Interestingly, phasic and tonic GABA(A) receptor (GABA(A)R)mediated neurotransmission is enhanced in the DG of Smad3-deficient mice, and LTP induction can be rescued by inhibiting GABA(A)R with picrotoxin. Hence, Smad3 signaling in the DG appears to be necessary to induce LTP by regulating GABA(A) neurotransmission, suggesting a central role of this intracellular signaling pathway in the hippocampal brain plasticity related to learning and memory.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available